Magainin Pharm (MAGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Magainin Pharm (MAGN)

MAGN 9.090

+6.2%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dave K who wrote (211)	9/30/1999 11:11:00 PM
From: Shlepper	Read Replies (1) of 233

Dave, It is unfortunate that the advisory panel poisoned the chances for Locilex - and the FDA did not have the smarts and guts to rectify the error. I'm not sure how Regranex can sell $150 m of product with no anti-infective properties and limited wound healing. The FDA - who I had always backed in the past - seem to have lost the science and have lapsed into procedures. The gifted have left for industry and the dolts remain.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next